Product image of Linezolida Normon (Linezolid) supplied by GNH India

Linezolida Normon

Active Ingredient:
Linezolid
Origin:
EU

Linezolida Normon (Linezolid)

Linezolid, the active ingredient in Linezolida Normon, is an oxazolidinone antibiotic presented as an oral dosage form for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult and pediatric patients when indicated.
GNH India supplies Linezolida Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratórios Normon, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for Gram‑positive bacterial infections and is employed across several clinical pathways.

  • Methicillin‑resistant Staphylococcus aureus (MRSA): effective treatment of infections caused by MRSA.
  • Vancomycin‑resistant Enterococcus (VRE): provides an alternative therapy for VRE infections.
  • Community‑acquired pneumonia: used to manage pneumonia caused by susceptible organisms.
  • Skin and soft‑tissue infections: treats cellulitis and other soft‑tissue infections due to Gram‑positive bacteria.
  • Infections caused by susceptible Gram‑positive bacteria: broad coverage for various infections where the pathogen is sensitive to linezolid.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal upset.
  • Diarrhea: loose stools, often mild.
  • Headache: occasional tension‑type headache.
  • Metallic taste: transient alteration of taste perception.
  • Vomiting: occasional emesis.
  • Insomnia: difficulty sleeping.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: nerve damage causing tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Optic neuropathy: visual disturbances, potentially irreversible.
  • Lactic acidosis: metabolic disturbance requiring urgent care.
  • Myelosuppression: bone‑marrow suppression affecting blood cell production.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety aspects.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes and observe for hepatic adverse events.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Prolonged therapy: regularly monitor complete blood counts for hematologic toxicity.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): can precipitate serotonin syndrome.
  • Rifampin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk.
  • Anticonvulsants (e.g., carbamazepine): may alter linezolid metabolism and efficacy.

Frequently Asked Questions

Linezolida Normon contains linezolid, an oxazolidinone antibiotic indicated for treating infections caused by susceptible Gram‑positive bacteria. It is commonly prescribed for conditions such as methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired pneumonia, and skin or soft‑tissue infections.

Linezolid works by binding to the 23S rRNA of the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect against a range of Gram‑positive organisms.

The prescribed dose of linezolid is determined by the treating physician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for linezolid during pregnancy and lactation are limited. It should be used only when the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers must evaluate each case carefully and discuss possible risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid is often compared with vancomycin, another agent for Gram‑positive infections. While vancomycin is administered intravenously and may cause nephrotoxicity, linezolid offers oral bioavailability and a different safety profile, though it carries risks of hematologic toxicity and serotonin syndrome. Choice depends on infection type, patient factors and susceptibility patterns.

Linezolida Normon should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight. Do not store in a refrigerator or freezer, and ensure the container is tightly closed when not in use.

Linezolida Normon is formulated for oral administration. The tablet (or other oral form) is taken by mouth with or without food, as directed by the prescriber. Patients should follow the exact dosing schedule and complete the full course of therapy, even if symptoms improve.

Serious risks associated with linezolid include thrombocytopenia, peripheral neuropathy, optic neuropathy, serotonin syndrome when combined with serotonergic drugs, and rare cases of lactic acidosis or severe myelosuppression. Patients should be monitored regularly for blood‑count changes and neurological symptoms.

Linezolida Normon should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones. Caution is advised for individuals taking serotonergic medications, those with uncontrolled hypertension, or patients with pre‑existing severe bone‑marrow suppression. The prescriber must assess suitability before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT